RSV F-PROTEIN-EPITOPE

Patent europeic · EP2950886 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2950886
Numer da la dumonda
EP14746750
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
31-01-2014
Publitgà
09-12-2015
Concedì
18-12-2019
La protecziun finescha il pli tard
30-01-2034
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61P 31/14 (2006.01)
Prioritad
US 201361759664 P 01.02.2013
US 201361783380 P 14.03.2013
Dumonda PCT
PCT/US2014/014054 31.01.2014
Publicaziun PCT
WO2014/121021 07.08.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 18-12-2019

    Concedì

    Published in Swissreg on 18.12.2019

Partidas

Possessur

MedImmune, LLC

One MedImmune Way, Gaithersburg, MD 20878, US

Inventur

ULBRANDT, Nancy

Gaithersburg, MD 20878, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.